428 related articles for article (PubMed ID: 24617977)
21. Physical and hormonal evaluation of transsexual patients during hormonal therapy.
Meyer WJ; Finkelstein JW; Stuart CA; Webb A; Smith ER; Payer AF; Walker PA
Arch Sex Behav; 1981 Aug; 10(4):347-56. PubMed ID: 6794543
[TBL] [Abstract][Full Text] [Related]
22. Effects of intramuscular testosterone undecanoate on body composition and bone mineral density in female-to-male transsexuals.
Mueller A; Haeberle L; Zollver H; Claassen T; Kronawitter D; Oppelt PG; Cupisti S; Beckmann MW; Dittrich R
J Sex Med; 2010 Sep; 7(9):3190-8. PubMed ID: 20584125
[TBL] [Abstract][Full Text] [Related]
23. Endocrine treatment of transsexual people: a review of treatment regimens, outcomes, and adverse effects.
Moore E; Wisniewski A; Dobs A
J Clin Endocrinol Metab; 2003 Aug; 88(8):3467-73. PubMed ID: 12915619
[TBL] [Abstract][Full Text] [Related]
24. A Review of the Status of Brain Structure Research in Transsexualism.
Guillamon A; Junque C; Gómez-Gil E
Arch Sex Behav; 2016 Oct; 45(7):1615-48. PubMed ID: 27255307
[TBL] [Abstract][Full Text] [Related]
25. Hormonal treatment reduces psychobiological distress in gender identity disorder, independently of the attachment style.
Colizzi M; Costa R; Pace V; Todarello O
J Sex Med; 2013 Dec; 10(12):3049-58. PubMed ID: 23574768
[TBL] [Abstract][Full Text] [Related]
26. Cross-sex hormone therapy in trans persons is safe and effective at short-time follow-up: results from the European network for the investigation of gender incongruence.
Wierckx K; Van Caenegem E; Schreiner T; Haraldsen I; Fisher AD; Toye K; Kaufman JM; T'Sjoen G
J Sex Med; 2014 Aug; 11(8):1999-2011. PubMed ID: 24828032
[TBL] [Abstract][Full Text] [Related]
27. Testicular Functions and Clinical Characterization of Patients with Gender Dysphoria (GD) Undergoing Sex Reassignment Surgery (SRS).
Schneider F; Neuhaus N; Wistuba J; Zitzmann M; Heß J; Mahler D; van Ahlen H; Schlatt S; Kliesch S
J Sex Med; 2015 Nov; 12(11):2190-200. PubMed ID: 26559385
[TBL] [Abstract][Full Text] [Related]
28. Cross-sex hormonal treatment and body uneasiness in individuals with gender dysphoria.
Fisher AD; Castellini G; Bandini E; Casale H; Fanni E; Benni L; Ferruccio N; Meriggiola MC; Manieri C; Gualerzi A; Jannini E; Oppo A; Ricca V; Maggi M; Rellini AH
J Sex Med; 2014 Mar; 11(3):709-19. PubMed ID: 24330520
[TBL] [Abstract][Full Text] [Related]
29. Sex differences in cortical thickness and their possible genetic and sex hormonal underpinnings.
Savic I; Arver S
Cereb Cortex; 2014 Dec; 24(12):3246-57. PubMed ID: 23926114
[TBL] [Abstract][Full Text] [Related]
30. Effects of three different testosterone formulations in female-to-male transsexual persons.
Pelusi C; Costantino A; Martelli V; Lambertini M; Bazzocchi A; Ponti F; Battista G; Venturoli S; Meriggiola MC
J Sex Med; 2014 Dec; 11(12):3002-11. PubMed ID: 25250780
[TBL] [Abstract][Full Text] [Related]
31. People with gender dysphoria who self-prescribe cross-sex hormones: prevalence, sources, and side effects knowledge.
Mepham N; Bouman WP; Arcelus J; Hayter M; Wylie KR
J Sex Med; 2014 Dec; 11(12):2995-3001. PubMed ID: 25213018
[TBL] [Abstract][Full Text] [Related]
32. [Morbidity in transsexual patients with cross-gender hormone self-treatment].
Becerra Fernández A; de Luis Román DA; Piédrola Maroto G
Med Clin (Barc); 1999 Oct; 113(13):484-7. PubMed ID: 10604171
[TBL] [Abstract][Full Text] [Related]
33. Sex differences in verbal fluency during adolescence: a functional magnetic resonance imaging study in gender dysphoric and control boys and girls.
Soleman RS; Schagen SE; Veltman DJ; Kreukels BP; Cohen-Kettenis PT; Lambalk CB; Wouters F; Delemarre-van de Waal HA
J Sex Med; 2013 Aug; 10(8):1969-77. PubMed ID: 23433223
[TBL] [Abstract][Full Text] [Related]
34. Cortical and trabecular bone mineral density in transsexuals after long-term cross-sex hormonal treatment: a cross-sectional study.
Ruetsche AG; Kneubuehl R; Birkhaeuser MH; Lippuner K
Osteoporos Int; 2005 Jul; 16(7):791-8. PubMed ID: 15502960
[TBL] [Abstract][Full Text] [Related]
35. Hormone-treated transsexuals report less social distress, anxiety and depression.
Gómez-Gil E; Zubiaurre-Elorza L; Esteva I; Guillamon A; Godás T; Cruz Almaraz M; Halperin I; Salamero M
Psychoneuroendocrinology; 2012 May; 37(5):662-70. PubMed ID: 21937168
[TBL] [Abstract][Full Text] [Related]
36. Changes in fat cell size and in vitro lipolytic activity of abdominal and gluteal adipocytes after a one-year cross-sex hormone administration in transsexuals.
Elbers JM; de Jong S; Teerlink T; Asscheman H; Seidell JC; Gooren LJ
Metabolism; 1999 Nov; 48(11):1371-7. PubMed ID: 10582544
[TBL] [Abstract][Full Text] [Related]
37. The Link between Estradiol and Neuroplasticity in Transgender Women after Gender-Affirming Surgery: A Bimodal Hypothesis.
Schneider MA; Spritzer PM; Suh JS; Minuzzi L; Frey BN; Schwarz K; Costa AB; da Silva DC; Garcia CCG; Fontanari AMV; Anes M; Castan JU; Cunegatto FR; Picon FA; Luders E; Lobato MIR
Neuroendocrinology; 2020; 110(6):489-500. PubMed ID: 31461715
[TBL] [Abstract][Full Text] [Related]
38. The effect of one-year cross-sex hormonal treatment on bone metabolism and serum insulin-like growth factor-1 in transsexuals.
van Kesteren P; Lips P; Deville W; Popp-Snijders C; Asscheman H; Megens J; Gooren L
J Clin Endocrinol Metab; 1996 Jun; 81(6):2227-32. PubMed ID: 8964856
[TBL] [Abstract][Full Text] [Related]
39. Cross-sex hormone administration changes pain in transsexual women and men.
Aloisi AM; Bachiocco V; Costantino A; Stefani R; Ceccarelli I; Bertaccini A; Meriggiola MC
Pain; 2007 Nov; 132 Suppl 1():S60-S67. PubMed ID: 17379410
[TBL] [Abstract][Full Text] [Related]
40. Mortality and morbidity in transsexual patients with cross-gender hormone treatment.
Asscheman H; Gooren LJ; Eklund PL
Metabolism; 1989 Sep; 38(9):869-73. PubMed ID: 2528051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
